Seraxis Names Former FDA Medical Officer Patricia Beaston As Chief Medical Officer Ahead Of Merger
(RTTNews) - Seraxis Holdings, Inc. and Sernova Biotherapeutics Inc. (SEOVF, SVA.TO), a biotechnology company developing cell-based therapies, on Monday announced the appointment of Patricia Beaston as Chief Medical Officer of Seraxis.